However, it should be recognised that single-nucleotide polymorphisms (SNPs) of SHBG gene are quite common in the general population, thus potentially affecting both SHBG circulating levels and its binding capacity. In clinical conditions that may interfere with SHBG levels (Table 3.3), evaluation of fT should be considered to better estimate actual androgen levels (Figure 3.1). Therefore, close collaboration between clinicians managing men with hypogonadism and local laboratories is strongly advised, reaffirming the need for a rigorous technical measurement methodology to ensure accuracy and comparability across laboratories. This limit may not be suitable for night-shift workers, as the diurnal rhythm of testosterone secretion is primarily driven by sleep patterns . Testicular and penile size, as well the presence of sexual secondary characteristics can provide useful information regarding overall androgen status. A man on TRT with the same numbers is simply showing evidence that the therapy is present and the feedback loop is working as expected. In these cases, low LH and FSH indicate secondary hypogonadism, meaning the testes are not underperforming on their own but are being deprived of the hormonal signal they need. Conditions affecting the pituitary, such as a pituitary adenoma or other structural lesion, can impair the production or release of LH and FSH. With such a high prevalence, hypogonadism is a candidate for the most common complication of male type 2 diabetes. However, clinicians have often not related low testosterone concentrations to clinical hypogonadism. In fact, those with low testosterone were 40% more likely to die (all-cause mortality) than those with higher levels. Data from the MMAS have demonstrated that there is a strong, positive relationship between HDL and testosterone in men with cardiovascular disease (low total or free testosterone correlates with low HDL cholesterol) (31). As discussed below, a measurement of low testosterone in a patient should be reconfirmed at a later stage before considering treatment. Current clinical guidelines recommend comprehensive baseline evaluation including complete blood count, lipid panel, prostate-specific antigen, and cardiovascular risk assessment before initiating testosterone replacement therapy. 2020 guidelines from the American College of Physicians support the discussion of testosterone treatment in adult men with age-related low levels of testosterone who have sexual dysfunction. Preliminary evidence suggests that low testosterone levels may be a risk factor for cognitive decline and possibly for dementia of the Alzheimer's type, a key argument in life extension medicine for the use of testosterone in anti-aging therapies. In people who have undergone testosterone deprivation therapy, testosterone increases beyond the castrate level have been shown to increase the rate of spread of an existing prostate cancer. These are phenotypically displayed as higher levels of anxiety and depression, mood dysregulation, impaired social skills, emotional immaturity during childhood, and low frustration tolerance. It is estimated that 10% of those with Klinefelter syndrome are autistic. Approximately 10% of males with XXY chromosomes have gynecomastia noticeable enough that they may choose to have surgery.citation needed Some will show few or no symptoms, a lanky, youthful build and facial appearance, or a rounded body type. For example, patients with 49 chromosomes (XXXXY) have more extreme manifestations than those with 48 chromosomes (XXXY). Chromosomal abnormalities, including Klinefelter syndrome, are the most common cause of spontaneous abortion. There have been some studies that suggest that COPD patients have a higher incidence of hypogonadism than the general population and that glucocorticoid treatment is only part of the reason. Low testosterone levels are correlated with insulin resistance in both epidemiological and interventional studies, and this may be attributable to the effect of testosterone on adiposity. There is an inverse relationship between serum total and free testosterone levels and visceral fat mass. A recent study (2009) from Italy demonstrates that testosterone treatment in elderly patients with chronic heart failure improves insulin sensitivity and various cardiorespiratory and muscular outcomes (37). Human observational studies, however, have shown no associations between high testosterone levels and coronary artery disease, and testosterone has been shown to dilate the coronary arteries both in vitro and in vivo.
